Skip to content

Effects of Different Colors of Light on Human Physiology

Mechanism Underlying the Effects of Blue Light in Humans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00200863
Enrollment
47
Registered
2005-09-20
Start date
2005-04-30
Completion date
2007-02-28
Last updated
2014-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circadian Rhythm, Healthy

Keywords

light, wavelength, action spectrum, circadian, melatonin, alertness, performance, arousal

Brief summary

This study will determine which color of light is most effective in stimulating a range of biological functions in humans including activation of sleep-wake regulatory system (alertness, performance, microsleeps, brain activity), activation of the nervous system (heart rate, temperature, blood pressure, breathing rate), and shifting the timing of the internal 24-hour (circadian) pacemaker.

Detailed description

Light has long been proposed to have a stimulatory effect on a range of biological functions in humans including increased feelings of activation, such as improved alertness or ability to perform. The mechanisms underlying how light stimulates these neurobiological systems remain to be elucidated. We propose to investigate the effects of different colors of light on human physiology, and in particular, test the claims that specific colors of light preferentially stimulate neurobiological, physiological and hormonal systems. Using classical photobiological techniques, we will construct action spectra for the effects of different colors of light on a range of non-image forming responses in humans. We will test the hypotheses that: 1) light-induced activation of the neurobiological sleep-wake regulatory system, as indicated by increased alertness, faster reaction time, suppression of EEG alpha activity, microsleeps and slow rolling eye movements, and suppression of pineal melatonin, is most sensitive to retinal exposure to short wavelength blue light (460 nm) compared to equal photons of other colors of visible light; 2) light-induced activation of autonomic and hypothalamic-pituitary-adrenal axis measures of arousal, as indicated by increased heart rate variability, core body temperature, blood pressure, respiration rate, plasma cortisol levels and urinary catecholamines, is most sensitive to exposure to short wavelength blue light (460 nm) compared to equal photons of other colors; 3) phase shifts of the human circadian pacemaker, as assessed by changes in temperature, melatonin and cortisol rhythms, are most sensitive to exposure to short wavelength blue light (460 nm) compared to equal photons of other colors. The resultant action spectra will help to identify the photoreceptor mechanism(s) by which light activates arousal and circadian resetting, these non-image-forming physiological responses and enable us to distinguish between major candidate photoreceptive mechanisms, including potential novel photoreceptor systems, that might mediate such responses.

Interventions

DEVICEMonochromatic visible light exposure

Monochromatic light in the visible range from 420-620 nm up to 60uW/cm2 for 6.5 hours

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH
Brigham and Women's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Free from any acute, chronic or debilitating medical, psychological, or ophthalmological conditions * Drug-free (including caffeine, nicotine, and alcohol) for entire study duration

Exclusion criteria

* History of drug or alcohol dependency * History of psychiatric illnesses or evidence of psychopathology according to standardized questionnaires, or in a structured clinical interview * Night shift work during the past 3 years * Transmeridian travel in the last 3 months

Design outcomes

Primary

MeasureTime frame
Subjective alertness prior to, during and after light exposure9.5 hours
Auditory psychomotor performance prior to, during and after light exposure9.5 hours
EEG power frequency prior to, during and after light exposure9.5 hours
Plasma melatonin and cortisol prior to, during and after light exposure60 hours
Heart rate, blood pressure, respiration rate and temperature prior to, during and after light exposure9.5 hours
Urinary catecholamines prior to, during and after light exposure32 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026